Abstract
Data are conflicting and sparse regarding the impact of high normal blood pressure (BP) (systolic BP (SBP) of 130–139 mm Hg or diastolic BP (DBP) of 85–89 mm Hg) on incident cardiovascular disease (CVD) among middle-aged vs elderly population. We examined the risk of BP categories among 6273 participants⩾30 years, free of CVD at baseline, during more than 9.3 years follow-up. Cox regression analysis was used to estimate the hazard ratio (HR) of CVD for normal BP group (SBP between 120–129 mm Hg or DBP between 80–85 mm Hg), high normal BP group and hypertension group (SBP⩾140 mm Hg or DBP⩾90 mm Hg or taking antihypertensive drugs), considering those with optimal BP (SBP<120 mm Hg and DBP<80 mm Hg) as reference. During follow-up, 512 CVD events occurred. There was significant interaction between age and BP categories (P=0.028) in prediction of CVD. In multivariate analysis, HRs (95% CIs) of CVD were 1.62 (1.11–2.37) and 2.20 (1.57–3.09) for middle aged with high normal and hypertensive BP groups, respectively. Among elderly (⩾60 years), HR was 2.09 (1.36–3.21) only for hypertensive ones. High normal BP is a risk factor for incident of CVD only among middle-aged population. Furthermore, the effect of hypertension on incident CVD was stronger among younger population.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012–2015
Scientific Reports Open Access 23 April 2019
-
Prehypertension and incidence of cardiovascular disease: a meta-analysis
BMC Medicine Open Access 02 August 2013
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Robinson SC, Brucer M . Range of normal blood pressure: a statistical and clinical study of 11,383 persons. Arch Intern Med 1939; 64 (3): 409–444.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360 (9349): 1903–1913.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42 (6): 1206–1252.
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25 (6): 1105–1187.
Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 2006; 47 (3): 410–414.
Kokubo Y, Kamide K, Okamura T, Watanabe M, Higashiyama A, Kawanishi K et al. Impact of high-normal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort: the Suita study. Hypertension 2008; 52 (4): 652–659.
Mainous 3rd AG, Everett CJ, Liszka H, King DE, Egan BM . Prehypertension and mortality in a nationally representative cohort. Am J Cardiol 2004; 94 (12): 1496–1500.
Greenlund KJ, Croft JB, Mensah GA . Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999–2000. Arch Intern Med 2004; 164 (19): 2113–2118.
Hadaegh F, Harati H, Ghanbarian A, Azizi F . Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. East Mediterr Health J 2009; 15 (1): 157–166.
Motlagh B, O’Donnell M, Yusuf S . Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur J Cardiovasc Prev Rehabil 2009; 16 (3): 268–280.
Azizi F, Rahmani M, Emami H, Madjid M . Tehran Lipid and Glucose Study: rationale and design. CVD Prev 2000; 3: 242–247.
Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M . Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009; 10: 5.
Hadaegh F, Harati H, Ghanbarian A, Azizi F . Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil 2006; 13 (4): 571–577.
Organization WH. http://www.who.int/classifications/icd/en/1990.
Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2002; 40 (7): 1366–1374.
Frohlich J, Dobiasova M, Adler L, Francis M . Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease. Physiol Res 2004; 53 (5): 481–486.
Baruch L . Hypertension and the elderly: more than just blood pressure control. J Clin Hypertens (Greenwich) 2004; 6 (5): 249–255.
Kleinbaum DG, Klein M . Survival Analysis, 2nd edn. Springer: New York City, 2005.
Wang Y, Wang QJ . The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 2004; 164 (19): 2126–2134.
Tsai PS, Ke TL, Huang CJ, Tsai JC, Chen PL, Wang SY et al. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens 2005; 23 (7): 1355–1360.
Agyemang C, Owusu-Dabo E . Prehypertension in the Ashanti region of Ghana, West Africa: an opportunity for early prevention of clinical hypertension. Public Health 2008; 122 (1): 19–24.
Sun Z, Zheng L, Wei Y, Li J, Zhang X, Liu S et al. Prevalence and risk factors of the rural adult people prehypertension status in Liaoning Province of China. Circ J 2007; 71 (4): 550–553.
Conen D, Ridker PM, Buring JE, Glynn RJ . Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ 2007; 335 (7617): 432.
Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345 (18): 1291–1297.
Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu L et al. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation 2007; 115 (7): 855–860.
Hadaegh F, Shafiee G, Hatami M, Azizi F . Systolic and diastolic blood pressure, mean arterial pressure and pulse pressure for prediction of cardiovascular events and mortality in a Middle Eastern population. Blood Press 2011 (e-pub ahead of print).
Gu D, Chen J, Wu X, Duan X, Jones DW, Huang JF et al. Prehypertension and risk of cardiovascular disease in Chinese adults. J Hypertens 2009; 27 (4): 721–729.
Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350 (9080): 757–764.
Mosley 2nd WJ, Greenland P, Garside DB, Lloyd-Jones DM . Predictive utility of pulse pressure and other blood pressure measures for cardiovascular outcomes. Hypertension 2007; 49 (6): 1256–1264.
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265 (24): 3255–3264.
O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376 (9735): 112–123.
Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999; 150 (4): 341–353.
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335 (8692): 765–774.
Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlof B et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375 (9718): 895–905.
Acknowledgements
This study was supported by Grant No.121 from the National Research Council of the Islamic Republic of Iran. We express appreciation to the participants of district 13, Tehran, for their enthusiastic support in this study. We would like to thank Ms N Shiva for the English editing of manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Hadaegh, F., Mohebi, R., Khalili, D. et al. High normal blood pressure is an independent risk factor for cardiovascular disease among middle-aged but not in elderly populations: 9-year results of a population-based study. J Hum Hypertens 27, 18–23 (2013). https://doi.org/10.1038/jhh.2011.112
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2011.112
Keywords
- prehypertension
- cardiovascular disease
- middle age
- elderly
This article is cited by
-
The association of stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline and subsequent cardiovascular events among adults <50 years
Journal of Human Hypertension (2020)
-
Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012–2015
Scientific Reports (2019)
-
Different combinations of glucose tolerance and blood pressure status and incident cardiovascular disease and all-cause mortality events
Journal of Human Hypertension (2017)
-
Dihydroquercetin Improves Microvascularization and Microcirculation in the Brain Cortex of SHR Rats during the Development of Arterial Hypertension
Bulletin of Experimental Biology and Medicine (2017)
-
High–normal blood pressure is associated with new-onset electrocardiographic left ventricular hypertrophy
Journal of Human Hypertension (2015)